EIF2AK4 and cancer: Several additional highly connected pathways were identified, including the RAF/MAP kinase cascade, mitotic metaphase and anaphase, and response of EIF2AK4 (GCN2) to amino acid deficiency, all of which are relevant to cancer progression and therapy resistance.